Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Leitz (Heidelberg, Germany), P. Konietzke (Heidelberg, Germany), M. Wielpütz (Heidelberg, Germany), M. Beers (Philadelphia, United States of America), M. Mall (Berlin, Germany), J. Duerr (Berlin, Germany), S. Fraumann (Heidelberg, Germany). LSC - 2019 - Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice. 2111

Member's Comments

No comment yet.

Related content which might interest you: Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Late Breaking Abstract - Il24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing the m2 program in macrophages Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019 Defective surfactant biosynthesis and ultrastructural abnormalities of alveolar type 2 cells in pulmonary fibrosis of conditional Nedd4-2mice Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Ageing Smad3 KO mice develop emphysema and are resistant to Transforming growth factor-β1 (TGF-β1) mediated pulmonary fibrosis Source: Annual Congress 2003 - Animal models of lung injury: useful or not? Year: 2003 Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 LSC - 2020 - GCN2 signalling is dysregulated in pulmonary fibrosis Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies Year: 2003 Stable lung function is maintained over 2 years in newborn screened (NBS) CF infants Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018 LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Tenascin C knockout mice have an altered lung function at newborn and adult age Source: International Congress 2017 – Molecular pathways in lung development Year: 2017 Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles Source: Eur Respir J 2004; 24 : 798-804 Year: 2004 Pseudomonas aeruginosa (Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 LSC - 2018 - Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Enhanced lung fibrosis in protein C inhibitor transgenic mice Source: Eur Respir J 2004; 24: Suppl. 48, 481s Year: 2004 LSC - 2020 - Glutathione-S-transferase P promotes Interleukin-1ß-induced inflammation and metabolic reprogramming in mice with allergic airways disease Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men Year: 2020 Involvement of coactivator associated arginine methyltransferase 1 (CARM1) in development of elastase-induced progressive emphysema Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Late Breaking Abstract - B cells are not involved in the regulation of adenoviral TGF-ß1- or bleomycin-induced lung fibrosis in mice Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021